SEC Form 4 · accession 0001209191-17-045396
Myovant Sciences Ltd. · MYOV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew Lang
Officer — General Counsel & Corp. Secy.
Period of report
Jul 17, 2017
Accepted (ET)
Jul 18, 2017 · 6:33 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001679082
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $11.30 | Jul 17, 2017 | A | 310,000 | A | — | Jul 16, 2027 | Common Stock | 310,000 | 310,000 | D |
Explanation of responses
- F11/4 of the shares underlying the option vest and become exercisable on July 17, 2018; and 1/16 of the shares underlying the option vest at the end of each quarter thereafter, measured from July 17, 2018, subject to the Reporting Person providing continuous service to the Issuer or its affiliates on each such date.